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Incorporation of 32P-orthophosphoric acid into pig ep-
idermal proteins was analyzed by sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis. The incorpora-
tion was observed in 2 major and 2 minor peaks with 
approximate molecular weights of 52,000 and 27,000, 
17,000, and 12,000 respectively. Treatment with epider-
:mal growth factor (EGF) consistently increased 32P in-
corporation into all 4 peaks. The stimulation was both 
time- and dose-dependent, and was not inhibited by the 
simultaneous addition of cycloheximide. 
In our previous study (submitted to J Invest Derma-
t;ol), we observed that EGF increased the cyclic GMP 
level in the same pig skin (epidermal) system. The pos-
sibility that the increased cyclic GMP leads to the protein 
phosphorylation observed in the present study was con-
sidered but ruled out because (1) the addition of cyclic 
GMP does not mimic the EGF treatment, (2) simultane-
ous addition of EGF and cyclic GMP stimulate phospho-
rylation to the same degree as the addition of EGF alone 
and (3) EGF stimulates phosphorylation in 20 min 
whereas the EGF induced increase in the cyclic GMP 
level takes 60 min. 
Epidermal growth factor (EGF) fu·st isolated from extracts of 
the male mouse submaxillary gland in 1962 by Cohen [1 ,2] 
stimulates epithelial cell proliferation, and also is a very potent 
mitoge n in other cells cultw-e system s [3]. 
Although the mechanism of action of this hormone in pro-
ducing its mitogenic effect h ave not been fully characterized, 
there have been several reports to suggest a role of cyclic 
nucleotides as a second m essenger in response to EGF [4-8]. 
W e have shown in previous studies of pig skin [9] that EGF 
had no effect on the cyclic AMP system but did have a stimu-
lating effect on the accumulation of intracellular cyclic GMP. 
The time course of the cyclic GMP inc rease did not suggest 
direct activation of guanylate cyclase; i.e., it took nearly 1 hr to 
observe the increase. 
In order to elucidate a possible physiologic role of the cyclic 
GMP increase in response to EGF, we examined t h e effect of 
EGF on protein phosphorylation. The increased phosphoryla-
tion of epidermal proteins in response to EG F becomes clear as 
early as 20 min after treatm ent, when cyclic GMP accw-nulation 
is still not evident. This effect of EGF was not mimicked by 
addition of cyclic GMP. 
Manuscript received August 16, 1979; accepted for publication De-
cember 6, 1979. 
This work was supported in part by grants AM 17179 from the 
National Institute of Health, the Dermatology Foundation of Miami, 
and Arthur 0. Wellman Fund. 
Reprint requests to: Dr. Kenneth Helprin, Veterans Administration 
Hospital, Department of Dermatology, University of Miami School of 
Medicine, Miami, FL 33125. 
Abbreviations: 
EGF: epidermal growth factor 
SDS: sodium dodecyl sulfa te 
TCA: trichloroacetic acid 
MATERIALS AND METHODS 
Skin slices were taken from the backs of domestic pigs, weighing 6-
8 kg, by a Castroviejo keratome set at 0.3 mm depth. During this 
procedure, pigs were anesthetized with Nembutal (dose = 20-30 mg/ 
kg) intraperitoneally. Skin slices were then cut in to 5 X 5 mm sq uares 
in Hank's balanced salt solution at 4°C and used within 30 min. After 
15 min preincubation at 37°C, treatment was started in the presence of 
both EGF and 32P-KH2PO, (0.025-0.5 mCi per ml). Incubation media 
was adjusted to pH 7.4 before use. Skin squares were floated in 
incubation media and at various incubation periods, 2 skin squares were 
taken out, rinsed in chilled Hank's balanced salt solut ion and immedi-
ately frozen between 2 Dry Ice plates. All frozen samples were kept at 
-70°C before analysis. Samples were homogenized twice with a glass 
homogenizer in 0.5 ml of 5% trichloracetic acid (TCA) at 4°C. The 
homogenates were centrifuged at 2,000 rpm for 20 min, and the pellet 
was resuspended in 1 ml of 5% TCA and centrifugation was repeated at 
2,000 rpm for 20 min. The pellet was then suspended in 100 JL1 of Tris-
HCl 0.1 M, pH 8.5, containing 8 M urea, 2% SDS (sodium dodecyl 
sulfate) 0.8% 2-mercaptoethanol and 1 mM phenyl methyl sulfonyl 
fluoride. The suspension was boiled at 100°C for 1 min and incubated 
at 37°C for 20 min. Total suspensions were centrifuged at 2,000 rpm for 
20 )Tiin and the supernatant was used for further study. Aliquots of 
supernatant were used for protein determination by Lowry et al [10), 
and for radioactivity determination. 
Acrylamide gels (7.5%) were prepared a day before use, as described 
by Fairbanks, Steck, and Wallach [11] with sligh t modification (con-
centration of SDS being 0.1 %). A sample of 10- 20 Ill, containing 50-100 
!Lg of proteins was applied to each disc gel. The gel was run in SDS 
running buffer at 5 rnA/ disc for 3.5 hr. After the electrophoresis, the 
gels were removed, stained for 15 hr with 0.1% Coomassie blue in 45 % 
methanol and 7% acetic acid , and destained in 45% isopropyl alcohol 
and 7% acetic acid solu t ion, followed by 7% acetic acid. The gels were 
then sliced into 1.6 mm sections and 2 slices each per counting vial 
were hydrolyzed in 0.5 ml of 30% hydrogen peroxide for 15-18 hr at 
60°C. Their radioactivit ies were determined by scintillation counter in 
toluene containing 0.4% Omnifluor, (New England Nuclear, Boston, 
Mass.) and 22% BBS III (Beckman, Anaheim, Calif.). Since the amount 
of proteins applied to the disc gel varies, the radioactivity of each sliced 
gel is corrected for the protein content. Namely, the "Unit-cpm/ /Lg 
protein" is defined by each 32P count (cpm) per slice divided by total 
protein (!Lg) which was subjected to gel analysis. Similarly the "Unit-
cp~/mg protein" is the same value multiplied by 1,000. 
· P-KH2PO, was purchased from New E ngland Nuclear (Boston, 
Mass.). EGF was obtained from Collaborative Research (Waltham, 
Mass.) Han~'s balanced salt solution was from GIBCO (Grand Island, 
N.Y.). Cyclic GMP and phenylmethyl sulfonyl fluoride were from 
Sigma (St. Louis, Mo.) . Acrylamide, N,N' -methylene-bis-acrylarnide, 
SDS, 2-mercaptoethanol, ammonium persulfate, N,N,N' ,N'-tetrameth-
ylethylenediamine, and Coomassie brilliant blue R-250, as well as 
molecular weight standards were purchased from Bio-Rad Labora tories 
(Rockville Center, New York) . All other chemicals were of analytical 
reagent grade. 
RESULTS 
The phosphorylation of TCA precipitated proteins was ex-
amined by SDS gel electrophoresis for both control a nd EGF-
stimulated skin. Proteins extracted from pig skin contain 2 
major (designated A and D) and 2 minor (designated Band C) 
phosphoproteins (Fig 1). The molecular weights of A, B, C, and 
D proteins, d etermined by comparison with standards, are 
52,000 27,000, 17,000 and 12,000, r espectively. These 32P-phos-
phoprotein b a nds were observable not only in the presence of 
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EGF but also in the absence of EGF. However, the EGF 
treatment always increased the incorporation of 32P as com-
pared with the control (Table I) and the difference between the 
treated and control is statistically significant. 
The data presented in Fig 2 illustrate the time course of 
phosphorylation in response to EGF. During the early time 
period in the presence of EGF, the A and D proteins were 
markedly phosphorylated. These increases in phosphorylation 
were apparent as early as 20 min after the EGF treatment (ref. 
Fig 1) . With longer incubations, the Band C proteins were also 
noticeably phosphorylated. As shown in Table II, the EGF 
effect could be detected at concentration as low as 0.1 f.Lg/ml. In 
order to exclude an effect of EGF on protein phosporylation 
requiring new protein formation, cycloheximide treatment was 
performed. As shown in Fig 3, two hr treatment with 1 x 10- 4 
M cycloheximide did not block the EGF-induced increase in 32P 
incorporation. 
We have previously reported a stimulatory effect of EGF on 
cyclic GMP levels with the same in vitro pig skin system. The 
increase in cyclic GMP required 1 hr and the increase was 
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FIG 1. SDS gel electrophoretic profiles of TCA precipitated pig 
epidermal phosphoproteins. One of 5 separate experiments is shown 
here. Incubation were · terminated by freezing pig skins and TCA pre-
cipitated proteins were extracted. Aliquots of extracts were subjected 
to SDS gel disc electrophoresis. Gels were stained and sliced into 1.6-
mm thick sections and their radioactivities (2 slices/counting vial) were 
determined as described under "Materials and Methods." Profiles of 
TCA precipitated proteins for control (e . ... e) and epidermis treated 
with 0.5J.lg/ml EGF for 20 min (0--0). Pictures mounted on top are 
a typical protein separation (lower panel) and molecular weight 
standards (upper panel): phosphorylase, bovine serum albumin, oval-
bumin, carbonic anhydrase, soybean trypsin inhibitor and lysozyme 
(from high (left) to low (right) molecular weight). 
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maximal at 6 hr after treatment. To understand the relation 
between the cyclic GMP increase and 32P-phosphorylation, the 
degree and initiation of phosphorylation by EGF and/ or cyclic 
GMP were further studied (Table III). Again the enhancement 
of phosphorylation in the 4 peaks was evident as early as 20 
min after the EGF treatment. The addition of cyclic GMP 
alone did not result in an increase in protein phosphorylation. 
Treatment with both EGF and cyclic GMP gave essentially the 
same degree of activation as EGF alone. 
DISCUSSION 
The lack of effect of added cyclic GMP on phosphorylation 
might be due to: (1) the added cyclic GMP not being able to go 
through the cell membrane; (2) the added amount may be 
inappropriate, or (3) nucleotide-phosphodiesterase might have 
digested the added cyclic GMP. Preliminary data, (unpub-
lished), suggest that cyclic GMP added at the concentration of 
10- 4 M is an adequate dose since more than 95% of added 
radioactive 3H cyclic GMP could be recovered in skin slices 
after 20 min of incubation. Also in ow· pig explant system the 
addition of cyclic GMP repeatedly stimulated epidermal cell 
outgrowth at a concentration of 10- • M [9]. Thus, these results 
do not support the hypothesis that EGF acts on protein phos-
phorylation in skin through the cyclic GMP system. Perhaps 
the increase in cyclic GMP after the EGF treatment is not the 
cause but the result of the phosphorylation. 
Huff and Guroff [12] reported that EGF treatment of chick 
embryo epidermis in culture media or chick embryos in vivo 
resulted in increased phosphorylation of a specific nuclear 
protein. The effect of EGF was mimicked by dibutyryl cyclic 
AMP and 3-isobutyl-1-methyl-xanthine, suggesting a primary 
role of cyclic AMP in response to EGF. On the other hand, 
Carpenter, King and Cohen [13] described the binding of EGF 
to membrane components from the human epidermoid carci-
noma cell line A-431. This resulted in a marked stimulation of 
the phosphorylation of endogenous proteins, but the presence 
of cyclic AMP or cyclic GMP had no discernible effect on the 
reaction. Our data that EGF has no effect on the cyclic AMP 
system in pig epidermis nor does cyclic AMP stimulate protein 
phosphorylation [9] is in accord with Carpenter, King, and 
Cohen. It does not support the idea that the EGF effect takes 
place through the cyclic AMP system. 
Although EGF does not stimulate cyclic AMP accumulation 
we have reported that cyclic GMP is stimulated by EGF. We 
considered that EGF might act on epidermal cells through the 
cyclic GMP system. The addition of EGF into the media of 
floating pig skin markedly increased both the cyclic GMP level 
and 32P incorporation into TCA precipitated epidermal pro-
teins. The present study clearly shows that increased protein 
phosphorylation was detected as early as 20 min after EGF 
treatment, at which time the intracellular level of cyclic GMP 
had not been increased. Furthermore, the addition of cyclic 
GMP did not induce phosphorylation and the combination 
treatment by both cyclic GMP and EGF did not stimulate 
TABLE I. Phosphorylation of epidermal proteins-20 min incubation with epidermal growth factor (EGF) 
Exp/ A B c D 
Pea ks EGF Control EGF Control EGF Control EGF Control 
1 11.8 10.1 2.87 2.08 2.98 1.99 5.27 4.04 
2 17.5 13.3 3.02 2.62 2.87 2.49 7.04 6.07 
3 14.6 12.3 2.74 2.39 2.72 1.86 5.83 5.80 
4 22.6 19.5 4.89 2.92 4.81 2.88 8.81 5.90 
5 21.0 17.8 4.44 2.68 4.03 2.46 8.43 8.27 
Average 17.5 14.6 3.59 2.54 3.48 2.34 7.08 6.02 
±SE ±1.99 ±1.75 ±.45 ±.14 ±.40 ±.18 ±.69 ±.67 
p value p < 0.001 p = 0.01 0.01 < p < 0.005 0.05 <p < 0.025 
The results are expressed as "unit cpm/J.lg protein." 
The values for Peak A are total of 3 counting vials at Peak A in duplicate, i.e., slice number 8 - 13, for Peaks B and C 2 vials in duplicate each, 
and for Peaks D 3 vials in duplicate respectively. EGF concentration was 0.5J.lg/ml. Statistical analysis by paired t-test. 
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FIG 2. Time course of the phosphorylation of TCA precipitated 
protein of pig epidermis in response to 0.5 JLg/ ml EGF. Th~ msert 
shows the extent of 32P incorporation into total extracted protems. The 
extent of 32P incorporation into each phosp~oprotein (Peaks A!B,C,D) 
were calculated from SDS gel electrophoretic proftles, as descnbed for 
Fig 1 (c.f. Results section). An average of 2 separate expe~ents, each 
run in duplicate, is shown. Dotted lines show theu respective controls 
(i .e.,....___ peak A EGF-treated and e .. . . peak A control) . 
TABLE II. Effect of EGF concentration on phosphorylation of 
epidermal proteins 
Total Peaks 
protein A B c D 
CPM/Jlg (unit- cpm/Jlg prot) 
prot 
Control 546 47.8 9.7 12.9 21.9 
EGF 0.1 581 79.5 13.8 15.3 31.9 
(fLg/ rnl) 0.5 631 86.2 17.4 17.5 36.4 
1.0 691 90.5 16.5 15.0 41.6 
5.0 745 93.1 17.4 21.1 41.5 
Each figure is an average of 2 independent experiments, each run in 
duplicate. The incubation period was 30 min. 
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FIG 3. Effect of cycloheximide on the EGF-induced phosphoryla-
tion-32P-phosphoprotein profiles of SDS gel electrophoresis. After 60 
min pretreatment with or without cycloheximide (lo-• M), samples 
were incubated for 60 min with 32P in the presence of EGF (0.5 j!g/ ml) 
and/or cycloheximide (1o- • M). Samples were processed as described in 
"Materials and Methods." Insert indicates 32P incorporation into the 
total extracted proteins. An average of 2 separate experiments, each 
run in duplicate: control (D---0), EGF alone (0--0), cycloheximide 
alone (.6--.6) and both EGF and cycloheximide treated (....___.) . 
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TABLE Ill. Protein phosphorylation by EGF, cyclic GMP, and EGF 
plus cyclic GMP 
Incubation Total Peaks 
period pro- c D tein A B 
min cpm/ Jlg unit cmp/ Jlg protein 
protein 
Control < 10 53.9 4.4 0.95 0.78 2.1 
20 123. 11.9 2.3 2.1 5.3 
EGF <10 57.4 5.7 1.1 0.89 2.2 
20 166. 14.6 2.9 2.9 6.0 
Cyclic GMP <10 50.0 3.9 0.87 0.88 1.8 
20 139. 13.0 2.5 2.6 5.8 
EGF <10 65.7 5.0 1.1 1.0 2.2 
& 20 173. 14.0 2.8 2.9 6.6 
Cyclic GMP 
Concentration of EGF was 0.5 j!g/ rnl and that of cyclic GMP 1 x 
w-• M. Each figure is an average of 3 experiments with an average 
standard error of mean of about 10%. 
further protein phosphorylation as compared with EGF treat-
ment alone. 
The stimulation by EGF of protein phosphorylation in the 
membrane preparation reported by Carpenter, King, and Cohen 
[13] and that reported here are in agreement on the fact that 
cyclic nucleotides are not involved. However, there are a num-
ber of differences in the systems, e.g. 32P-ATP was used in the 
membrane system and was allowed to react at 0°C. The isolated 
proteins were of larger molecular weight than those reported 
here and they did not use urea in the gels. Since over 90% of 
our 32P labeled material was destroyed by RNA-ase and trypsin, 
both.systems assessed proteins and not lipids. The relationship 
between these systems remains to be explored. 
Since the phosphorylated proteins are not characterized, it is 
not possible to elucidate changes in specific metabolic altera-
tions which may have been induced by EGF in intact cells. We 
have shown in an explant system of pig epidermis that EGF 
can increase migration and/or proliferation [9]. These effects 
might be initiated by increased protein phosphorylation, which 
was shown in the present study. At the present time the precise 
mechanism by which EGF enhances phosphorylation is not 
known, but it is believed to be a result of binding to the cell 
membrane [14]. EGF may increase membrane permeability, 
allow ion exchange and activate ca++ dependent protein kinase, 
resulting in protein phosphorylation, as described by Schulman 
and Greengard [15]. 
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Announcements 
The Department of Dermatology of Stanford University School of Medicine is sponsoring a Podiatric 
Dermatology Symposium July 8-10, 1980, which is designed for dermatologists, podiatrists and family 
practitioners and will emphasize the diagnosis and management of common dermatologic problems 
involving the foot. For further information, please contact: Paul H. Jacobs, M.D., Department of 
Dermatology, Stanford University School of Medicine, Stanford, CA 94305, or phone (415) 497-6101. 
